Thematic Investing - STOXX EconSight Q&A Thematic strategies to capture evolving technologies such as AI and quantum We spoke with the STOXX Thematics team to discuss how we use patent-based data, advanced taxonomies, and annual reports to capture cutting-edge themes such as AI, defense, and quantum computing. If you would [...]
EconSight at QuantumBasel Event Yesterday, EconSight gave a presentation at the QuantumBasel Quantum & AI Summit in Basel, focused on finance. We highlighted the global development of quantum computing, as well as the leading companies across key quantum applications including AI, encryption, and fintech. Beyond our presentation, three broader themes stood [...]
China Technology Monitor 2026 China on its way to becoming the leading technology nation One of the reasons why China is taking such an aggressive stance in the trade conflict with the US is the significant progress it has made in strategically relevant technologies in recent years. [...]
New Future Water ETF Joint presentation of the new Deka Future Water ETF FONDS professionell Congress presentation Deka and EconSight jointly presented the new Deka STOXX Future Water ETF at the FONDS professionell Congress. The ETF comprises around 60 companies with involvement in the water sector, [...]
Industrial AI Top Industrial AI Companies: Siemens in the Lead EconSight's contribution at the World Economic Forum in Davos 2026 From a technological perspective, this year's World Economic Forum in Davos is all about AI, especially applications. In our talks, we tried to shift the focus from [...]
The World of GenAI - Top Companies in Generative AI The World of GenAI - Top Companies in Generative AI The World of GenAI - Top Companies in Generative AI View animation full screen The world of GenAI in [...]
Genmab after Merus acquisition Genmab strengthens position among global immunotherapy leaders with Merus acquisition From a patent perspective, the acquisition represents a highly strategic move. Genmab now advances to position 25 among the leading immunotherapy companies, measured by the number of world-class patents. This transaction further strengthens [...]
BioNTech and CureVac after takeover BioNTech among top players in mRNA and vaccines after CureVac acquisition The planned acquisition of CureVac announced yesterday makes strategic sense for BioNTech. BioNTech justifies the acquisition with its improved positioning in mRNA technologies. [...]
Big Tech Shootout USA vs China - Pt. 2 - Advanced Digital Technologies The chart shows the technological activities as world shares held by the company in each technology. World share is defined as the share of company world class patents in total global patents in [...]
Big Tech Shootout USA vs China - Pt. 1 - Human-Machine-Interface Technologies The chart shows the technological activities as world shares held by the company in each technology. World share is defined as the share of company world class patents in total global patents in a technology. A bubble position to the right shows [...]
Humanoid Robots Humanoid Robots Technology Overview Humanoid robots represent a very dynamic emerging technology focused on designing machines that replicate human form and function. This domain integrates several technical sub-themes, including joint mechanisms and control systems, which are crucial for achieving stable, human-like locomotion. These systems often employ advanced methods to [...]
Quantum Technology Quantum Computing Technology Overview The technology has made a breakthrough in recent years, which is reflected in the significant increase in patents, but also in the number of active countries and companies. While a few years ago a few companies dominated the field, the technology is now becoming more widespread. It is [...]
Hydrogen mobility in China Hydrogen mobility in China - Opportunities for German companies Together with Automotiveland NRW and German Trade and Invest GTAI, EconSight discussed "Hydrogen mobility in China - Opportunities for German companies!" In a packed forum, the speakers were able to cover a wide range of topics [...]
Artificial Intelligence Race in Big Pharma Roche is leading the AI race in Big Pharma since 2007 The race for AI in Big Pharma is on. An extensive social media discussion in recent days has been about AI research papers in Big Pharma. Here is the patent perspective: Roche has [...]
EconSight AI research project with ZHAW and the University of Basel EconSight AI research project with Zurich University of Applied Sciences and the University of Basel EconSight maintains close relationships with many universities and research institutions in Europe, Asia and North America to identify and assess key future technologies. [...]
Fuel Cells – Developments and Obstacles EconSight presentation at the Industrialisation of Hydrogen Technology Forum, Nanjing EconSight presented the following charts and arguments at the Industrialisation of Hydrogen Technology Forum in Nanjing, hosted by the China Electrotechnical Society and the Electric Vehicle Association of Asia-Pacific. The EconSight contribution takes the fuel cell development during the [...]
AI and Healthcare at the BioData World Congress in Basel Artificial Intelligence in Basel and in Switzerland Panel discussion at the BioData World Congress What are the implications of a globally accelerating AI innovation for Basel and Switzerland? That was the key question at the BioData World [...]
EconSight CTO Jochen Spuck about the future of mobility Listen to the new Moove podcast from Auto Motor Sport with Jochen Spuck, CTO EconSight, about the future of mobility, technological challenges, new players and the role of the German automotive industry. (Postcast in German).
Swiss Atlas of Digitization Swiss Atlas of Digitization EconSight introduces the Digitization Atlas on the state of advanced digitization in Switzerland. The digitization atlas shows the patent activities of companies in advanced digitization technologies in Switzerland - by company location and regionalized down to the postcode level. This makes Switzerland's [...]
New Siemens In May 2019, Siemens announced the sale of its Gas and Power Business Area, consisting of conventional power generation and transmission as well as oil and gas. In recent years, Siemens has already transferred several technology areas to independent units or companies. These include medical technology (Healthineers), wind energy [...]